Successful Treatment of Antibody-mediated Pure Red Cell Aplasia Induced by Continuous Erythropoietin Receptor Activator with Prednisolone

Pure red cell aplasia (PRCA) associated with erythropoiesis-stimulating agents (ESAs), which were first reported in 1998, usually occurs with subcutaneous administration of epoetin alfa (Eprex(Ⓡ)). Improvements in ESA storage, handling, and administration methods have reduced the PRCA incidence. Con...

Descripción completa

Detalles Bibliográficos
Autores principales: Okahashi, Nozomi, Kubo, Masayuki, Hoshino, Ei, Uchihara, Masahito, Amano, Itsuto, Tanaka, Haruyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381349/
https://www.ncbi.nlm.nih.gov/pubmed/34980800
http://dx.doi.org/10.2169/internalmedicine.8823-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9381349/
https://www.ncbi.nlm.nih.gov/pubmed/34980800
http://dx.doi.org/10.2169/internalmedicine.8823-21

Ejemplares similares